Should the vCJD policy be changed in wake of the new revelations in the U.K. concerning plasma products?
Canadian Blood Services will continue to monitor the situation in the U.K. and keep Canadians informed of all potential risks to the blood system. Canadian Blood Services’ current policy effectively protects against the risk of vCJD being transferred through blood and blood products. Changes to the current vCJD policy will be made should they be deemed necessary. Canadian Blood Services will carefully monitor the development of new technologies to either remove vCJD from blood, or test for the presence of the disease in blood.